Ethics and Public Policy Center president Ryan T. Anderson backs Hawley's bill to revoke mifepristone's approval

Ryan T. AndersonPresident of the Ethics and Public Policy Center, in a statement of support released through Senator Hawley's office

Defended or excused

Ryan T. Anderson, president of the Ethics and Public Policy Center, said in a statement of support released through Senator Hawley's office that chemical abortion kills babies, harms women and is not a legitimate form of healthcare. He thanked Hawley for a bill revoking what he called the drug's misguided approval.

“Chemical abortion kills babies and harms women. Deadly to babies, it is significantly more dangerous to women than the FDA has let on. It is not a legitimate form of healthcare because it is not healthcare at all. A decent society would not approve it as if it were a legitimate medicine. Thank you to Senator Hawley for this bill revoking its misguided approval”

Official statement

Read the official statement (opens in a new tab)Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.

Official statement

Read the official statement (opens in a new tab)Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

Case updates

Tracking Josh Hawley's push to ban the abortion pill

Get an email if the mifepristone bill moves in committee or gains cosponsors, or if candidates sign or reject Hawley's Declaration for Life pledge.

Important updates only. Free. Confirm your email to start. Unsubscribe anytime. How we handle your email.

Conceptual image of generic white tablets in a blister pack beneath a shadow resembling the U.S. Capitol.
Credit: The Dispute Index / AI-generated illustration

Where this statement fits

Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.

Read the full case

Source and context

Official statement

Statements of Support for the Safeguarding Women from Chemical Abortion Act (opens in a new tab) · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.

About this source

Two-page compilation of statements of support for the bill from eight anti-abortion organizations, released by Senator Hawley's office and linked from his March 11, 2026 announcement of the bill.

Archived copy (opens in a new tab)

Official statement

Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders (opens in a new tab) · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

About this source

Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.

Archived copy (opens in a new tab)

Before the quotation

Hawley introduced the Safeguarding Women from Chemical Abortion Act on March 11, 2026. His release named the Ethics and Public Policy Center among the eight organizations supporting it and linked their statements of support.

After the quotation

The same two-page document carries statements of support from seven other organizations, including Susan B. Anthony Pro-Life America and Students for Life of America.

How this statement is classified

Defended or excused

The label describes this statement's response within the context above.

Why this label?

The case's reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its FDA approval. Anderson thanks Hawley for the bill and calls the drug's approval misguided, which is clear support for the proposal, so we labeled it Defended or excused.

Recorded on
Published here
People and groups discussed
Josh Hawley

More from this case

Read the full case

Share or embed this statement

Quote card: Ryan T. Anderson, Ethics and Public Policy Center president Ryan T. Anderson backs Hawley's bill to revoke mifepristone's approvalDownload image (PNG)

The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.

Cite this record

Publisher
The Dispute Index
Title
Ethics and Public Policy Center president Ryan T. Anderson backs Hawley's bill to revoke mifepristone's approval
First published
Last updated
Permalink
https://disputeindex.com/events/3391-ryan-t-anderson-president-of-the-ethics-and

Last updated marks the most recent saved version of this published statement.

The Dispute Index. "Ethics and Public Policy Center president Ryan T. Anderson backs Hawley's bill to revoke mifepristone's approval". First published: 2026-09-30. Last updated: 2026-09-30. https://disputeindex.com/events/3391-ryan-t-anderson-president-of-the-ethics-and